GSE214931 temozolomide 1 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE214931_temozolomide_1_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE214931_temozolomide_1_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE214931_temozolomide_1_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE214931_temozolomide_1_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

uncharacterized LOC339260

Gene

SLC16A1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 3052

Gene

uncharacterized LOC105371773

Gene

IGFL2 antisense RNA 1

Gene

arylacetamide deacetylase pseudogene 1

Gene

XG Y-linked 2 (pseudogene)

Gene

PDCD6IP pseudogene 2

Gene

FOXF1 adjacent non-coding developmental regulatory RNA

Gene

HECW2 antisense RNA 1

  • Gene

    uncharacterized LOC339260


  • Gene

    SLC16A1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 3052


  • Gene

    uncharacterized LOC105371773


  • Gene

    IGFL2 antisense RNA 1


  • Gene

    arylacetamide deacetylase pseudogene 1


  • Gene

    XG Y-linked 2 (pseudogene)


  • Gene

    PDCD6IP pseudogene 2


  • Gene

    FOXF1 adjacent non-coding developmental regulatory RNA


  • Gene

    HECW2 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.